Esophagogastroduodenoscopy (EGD)
Esophagogastroduodenoscopy (EGD) is a medical procedure with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer
Detection of Barrett s Esophagus in Patients Without GERD Symptoms
The Maternal EED Study
Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy
Clinical Trials (8)
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer
Detection of Barrett s Esophagus in Patients Without GERD Symptoms
The Maternal EED Study
Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy
EUS vs EGD in Emergency Room Patients Referred for EGD
Barrett's Dysplasia Detection Pilot Trial Using the NvisionVLE® Imaging System
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
All 8 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 8